Pharmaceuticals companies may be affected by industry competition, dependency on a limited number of products, obsolescence of products, government approvals and regulations, loss or impairment of intellectual property rights and litigation regarding product liability
In clinical trials, retatrutide has been administered as a once-weekly subcutaneous injection
Its everywhere
If clinical suspicion persists despite low or negative antibody levels, fine-needle aspiration biopsy (FNA) and cytologic examination are recommended
The lack of regulation and limited clinical research further complicate the picture, leaving much about its safety uncertain
IUPHAR, PubChem, and NCBI MeSH provide the safest starting points because they support entity identity without commercial claims [1], [2], [3]